In managing wounds it remains a common practice to either use soap and water or stronger solutions. The problem is that soap and water are ineffective against some pathogens whereas many stronger solutions potentially disturb the healing process, and potentially damage human cells.
Granudacyn® is your go-to wound cleanser – cleaning wounds, supporting healing.
.
Did you know.....
that wound cleansers support wound healing by removing
local barriers and reducing the risk of infection?
Granudacyn® is an irrigation solution, preserved by hypochlorous acid (HOCl). It is used for cleansing and moisturising hard-to-heal, acute, surgical and contaminated wounds as well as for superficial and partial-thickness burns. It can also be applied on sensitive tissues, such as cartilage, tendons, ligaments and bones
-
Effective on various types of wounds
Granudacyn can be used on all hard-to-heal wounds, including diabetic foot ulcers, all forms of leg ulcers and pressure injuries. Additionally, it can be used on acute and contaminated wounds as well as superficial and partial-thickness burns. - Better care, better quality of life
Reducing infections through mechanical rinsing, supporting the natural healing process of wounds. - Long storage, always at hand
Granudacyn can be stored at room temperature after opening for multiple use for up to 90 days (gel) and 60 days (solution).
Apply Granudacyn to the wound bed before cleansing the wound. The solution does not require neutralisation or rinsing, and can be used for moistening the wound dressing and moisturising the wound itself.
|
The presence of HOCl/NaOCI in the solution acts as a preservative. The bioburden tests, conducted according to the guidelines, confirm the microbial purity of the product. This indicates that there are no bacteria present in our solution, ensuring the purity of our product. |
Granudacyn facilitates the mechanical removal of microorganisms and cell debris |
Setting up the body to heal
Granudacyn is non-cytotoxic and does not cause irritation
Biocompatible
Granudacyn is proven to be biocompatible, meaning that it has a positive benefit/risk ratio
AUWC_001110
'References'
